✉news ScienceBiology first seen 6 d ago, last 6 d ago, peak #2
MitoCareX Bio Expands Computational Biology Platform Nexentis
Original: Nexentis: MitoCareX Bio Expands Computational Biology Capabilities to Advance Disease-Pathway Analysis
Biotech company MitoCareX Bio announced an expansion of its computational biology capabilities through its Nexentis platform, aimed at advancing disease-pathway analysis. The company says the move will strengthen its ability to model mitochondrial-related disease mechanisms and support drug discovery research.
Why now: The company issued a press release announcing the expansion of its computational biology platform.
Evidence
- Nexentis: MitoCareX Bio Expands Computational Biology Capabilities to Advance Disease-Pathway Analysis · GlobeNewswire
API: https://socialmediatrends-api.osmike.com/v1/trends/1984419